Dr. Virginia L Maher Wiese

Dr. Virginia L Maher Wiese (DR. VIRGINIA L MAHER WIESE ) is A Dermatology Physician in Essex, CT. The NPI Number for Dr. Virginia L Maher Wiese is 1396700217.

The current location address for Dr. Virginia L Maher Wiese is 20 SAYBROOK ROAD Essex, CT 06426 and the contact number is 8607679998 and fax number is 8607679161. The mailing address for Dr. Virginia L Maher Wiese is 20 SAYBROOK ROAD Essex, CT 06426- 8607679998 (mailing address contact number - 8607679998).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Dr. Virginia L Maher Wiese ?

Answer: The NPI Number for Dr. Virginia L Maher Wiese is 1396700217

Where is Dr. Virginia L Maher Wiese located?

Answer: Dr. Virginia L Maher Wiese is located at 20 SAYBROOK ROAD Essex, CT 06426.

What is the specialty for Dr. Virginia L Maher Wiese ?

Answer: The Specialty of Dr. Virginia L Maher Wiese is A Dermatology Physician.

Are there any online reviews for Dr. Virginia L Maher Wiese ?

Answer: Yes! Check It Now.

Are there any other health care providers in Essex, CT?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Virginia L Maher Wiese

Number of HCPCS	34
Number of Medicare Beneficiaries	585
Number of Services	5213
Total Submitted Charge Amount	413999.85
Total Medicare Allowed Amount	266598.85
Total Medicare Payment Amount	195014.11
Total Medicare Standardized Payment Amount	173825.75
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	2
Number of Medicare Beneficiaries With Drug Services	11
Number of Drug Services	20
Total Drug Submitted Charge Amount	5888.14
Total Drug Medicare Allowed Amount	3925.44
Total Drug Medicare Payment Amount	3140.32
Total Drug Medicare Standardized Payment Amount	3077.52
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	32
Number of Medicare Beneficiaries With Medical	585
Number of Medical Services	5193
Total Medical Submitted Charge Amount	408111.71
Total Medical Medicare Allowed Amount	262673.41
Total Medical Medicare Payment Amount	191873.79
Total Medical Medicare Standardized Payment Amount	170748.23
Average Age of Beneficiaries	77
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	239
Number of Beneficiaries Age 75 to 84	253
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	361
Number of Male Beneficiaries	224
Number of Non-Hispanic White Beneficiaries	548
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement	18
Number of Beneficiaries With Medicare Only Entitlement	567
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.11
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.04
Percent (%) of Beneficiaries Identified With Asthma	0.04
Percent (%) of Beneficiaries Identified With Cancer	0.14
Percent (%) of Beneficiaries Identified With Heart Failure	0.08
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.15
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.06
Percent (%) of Beneficiaries Identified With Depression	0.14
Percent (%) of Beneficiaries Identified With Diabetes	0.13
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.61
Percent (%) of Beneficiaries Identified With Hypertension	0.56
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.23
Percent (%) of Beneficiaries Identified With Osteoporosis	0.11
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.39
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke	0.03
Average HCC Risk Score of Beneficiaries	0.8625

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	1135
Number of Standardized 30-Day Fills	1216.9
Aggregate Cost Paid for All Claims	83786.32
Number of Day's Supply for All Claims	28676
Number of Medicare Beneficiaries	457
Number of Claims, Including Refills, for Beneficiaries Age 65+	1117
Including Refills, for Beneficiaries Age 65+	1198.9
Beneficiaries Age 65+	82429.92
Number of Day's Supply for All Claims for Beneficaries Age 65+	28295
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	53
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	1082
Aggregate Cost Paid for Generic Drugs	51002.06
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	529
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	50039.83
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	606
Aggregate Cost Paid for Claims Filled by	33746.49
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	104
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	4542.08
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	1031
by Low-Income Subsidy	79244.24
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	124
Aggregate Cost Paid for Antibiotic Drugs	4252.22
Antibiotic Claims	54
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	75.763676149
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	289
Number of Male Beneficiaries	168
Number of Non-Hispanic White	428
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	23
Only Entitlement	426
Average Hierarchical Condition Category	0.8697146244